QuantalX Collaborates with University of Illinois Chicago to Accelerate US Market Entry

Thursday, June 06, 2024

QuantalX Neuroscience Ltd, an innovative medical technology company, proudly announces its partnership with the Department of Neurology and Rehabilitation at the University of Illinois Chicago (UIC). This collaboration represents a pivotal step towards QuantalX's US market expansion.

UIC Health, encompassing a 445-bed tertiary care hospital, over 30 outpatient clinics, 11 federally qualified health centers, and numerous patient-focused research facilities, operates across campuses in Chicago, Peoria, the Quad Cities, Rockford, Springfield, and Urbana.

The health system integrates the academic, training, and research endeavors of UIC's seven health science colleges, all dedicated to promoting health equity.

The first study aims to predict neurological decline in patients with acute ischemic stroke (AIS), while the second examines brain physiological changes in Sickle Cell Disease (SCD) patients, investigating the correlation between SCD severity and cognitive impairments.

This collaboration signifies a major leap forward in QuantalX's mission to revolutionize brain health care through precise neuro-physiological assessments and cutting-edge predictive analytics.

It showcases the remarkable potential of Delphi-MD to improve patient care decisions and outcomes, establishing a robust foundation for its US commercialization.

"Excited about Delphi-MD and our collaboration with QuantalX. This partnership could lead to targeted interventions, potentially enhancing outcomes for these patients."







Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare CNO Summit - USAHealthcare CMO Summit - USAHealthcare CFO, Financial Strategy & Revenue Cycle SummitHealthcare CEO & Executive Strategy Summit